PAVmed reports positive DisappEAR animal study results
PAVmed, a highly differentiated, multiproduct medical device company, announced that its DisappEAR resorbable pediatric ear tube achieved a major developmental milestone with the successful completion of a 90-day study in an established animal model to support a planned US Food and Drug Administration (FDA) 510(k) submission later this year.